This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Vaginal preparations

Authoring team

  • local oestrogens in the form of pessaries or cream, ring or tablets can help dyspareunia, atrophic vaginitis, or recurrent urinary tract infections
  • topical oestrogens should be used in the minimum effective amount to minimise oestrogen absorption; if topical preparations are used long-term then some require oral progestogen for 10-14 days of each month to combat development of endometrial hyperplasia (1)

In the context of safety of usage of topical oestrogens, the Committee on Safety of Medicines has stated (2):

  • topical oestrogens should be used in the lowest effective amount to minimise systemic absorption
  • treatment should be interrupted at least annually to re-assess the need for continued treatment
  • if break-through bleeding or spotting appears at any time on therapy, the reason should be investigated and may include endometrial biopsy to exclude endometrial malignancy

Reference:

  1. BNF 7.2
  2. Currrent Problems in Pharmacovigilance (2003), 29, 3.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.